ArticleInternational journal of oncology2025

Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model.

A Young Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.